CASI Pharmaceuticals, Inc. cotiza a 0.11 USD y tiene una capitalización bursátil de $2M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People's Republic of China, the United States, and internationally. It offers EVOMELA, a Melphalan injection for use as a conditioning treatment prior to stem cell transplantation and as …
| Periodo | 2026-05 | 2025-11 | 2025-08 | 2025-05 |
|---|---|---|---|---|
| Real | $-0.36 | $-0.67 | $-0.86 | $-0.69 |
| Estimado | $-0.36 | $-0.40 | $-0.47 | $-0.61 |
| Sorpresa | +0.0% | -67.5% | -83.0% | -13.1% |
| Métrica | CASIF | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 48.6% | 57.0% | -8.4% |
| Operating Margin | -217.3% | -38.6% | -178.7% |
| Net Margin | -232.0% | -33.6% | -198.5% |
| FCF Margin | -100.3% | -13.9% | -86.4% |
| ROE | — | -40.4% | — |
| ROA | -187.4% | -32.0% | -155.4% |
| Current Ratio | 0.27 | 2.84 | -2.57 |
| Debt / Equity | — | 0.28 | — |